KaloBios Pharmaceuticals, Inc. Announces Two Significant Additions to Its Management Team

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KaloBios Pharmaceuticals, Inc. today announced the appointments of two significant additions to the company’s senior management team. Jonathan Leff, M.D., previously Vice President and Chief Medical Officer of Halozyme Therapeutics, Inc., has been named Chief Medical Officer. Gary A. Lyons, former President and Chief Executive Officer of Neurocrine Biosciences, Inc., has been elected to the KaloBios Board of Directors.